{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T16:13:29Z","timestamp":1758125609590,"version":"3.41.2"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T00:00:00Z","timestamp":1673481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Radiotherapy plays an important role in the treatment of lung cancer. However, radiation-related deaths from cardiovascular disease (CVD) are a concern in these patients, and few studies have examined CVD-related death associated with lung cancer. We aimed to evaluate the risk of CVD-related death after radiotherapy in patients with lung and bronchus cancer.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Data were extracted from the surveillance, epidemiology, and end results database. Propensity score matching (PSM) was applied to reduce possible bias between patients who received radiotherapy and those who did not. The Kaplan\u2013Meier method was used to estimate cardiovascular-specific survival (CVSS), and the log-rank test was used to compare CVSS between the radiotherapy and no radiotherapy groups. Cox proportional hazards regression analysis was performed to estimate the hazard ratio (HR) of CVD-related death.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 225,570 patients with lung and bronchus cancer were included, and 201,282 patients remained after PSM. Radiotherapy was identified as an independent risk factor for CVSS among patients with lung and bronchus cancer before PSM (HR: 1.18, <jats:italic>P<\/jats:italic> &amp;lt; 0.001) and after PSM (HR: 1.18, <jats:italic>P<\/jats:italic> &amp;lt; 0.001). Patients treated with radiotherapy had a significantly worse CVSS than those who did not receive radiotherapy before PSM (25-year CVSS: 49.9 vs. 56.4%, <jats:italic>P<\/jats:italic> = 0.002) and after PSM (25-year CVSS: 48.4 vs. 56.7%, <jats:italic>P<\/jats:italic> &amp;lt; 0.001). Radiotherapy was associated with more deaths from heart disease before PSM (81.9 vs. 77.2%, <jats:italic>P<\/jats:italic> &amp;lt; 0.001) and after PSM (83.0 vs. 78.7%, <jats:italic>P<\/jats:italic> &amp;lt; 0.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Radiotherapy is associated with an increased risk of CVD-related death, especially death from heart disease, in patients with lung and bronchus cancer. More efforts are needed to monitor cardiovascular health after radiotherapy.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2022.1068957","type":"journal-article","created":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T05:33:31Z","timestamp":1673501611000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Association between radiotherapy and risk of death from cardiovascular diseases in lung and bronchus cancer"],"prefix":"10.3389","volume":"9","author":[{"given":"Zhong","family":"Yi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangnan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songwei","family":"Ru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingxuan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.5334\/aogh.2419","article-title":"Global epidemiology of lung cancer.","volume":"85","author":"Barta","year":"2019","journal-title":"Ann Glob Health."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20010024","article-title":"Combining radiotherapy and immunotherapy in lung cancer: can we expect limitations due to altered normal tissue toxicity?","volume":"20","author":"Wirsd\u00f6rfer","year":"2018","journal-title":"Int J Mol Sci."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10081647","article-title":"Cancer therapy-related cardiovascular complications in clinical practice: current perspectives.","volume":"10","author":"Bohdan","year":"2021","journal-title":"J Clin Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/s41569-020-0348-1","article-title":"Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia.","volume":"17","author":"Herrmann","year":"2020","journal-title":"Nat Rev Cardiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00066-018-1378-z","article-title":"Heart toxicity from breast cancer radiotherapy : current findings, assessment, and prevention.","volume":"195","author":"Piroth","year":"2019","journal-title":"Strahlenther Onkol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/S1470-2045(05)70251-5","article-title":"Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries.","volume":"6","author":"Darby","year":"2005","journal-title":"Lancet Oncol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.rpor.2019.09.002","article-title":"Cardiotoxicity of mediastinal radiotherapy.","volume":"24","author":"Ratosa","year":"2019","journal-title":"Rep Pract Oncol Radiother."},{"key":"B8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.tcm.2019.01.006","article-title":"Cardioprotective strategies to prevent breast cancer therapy-induced cardiotoxicity.","volume":"30","author":"Padegimas","year":"2020","journal-title":"Trends Cardiovasc Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"448","DOI":"10.21037\/jtd.2017.02.75","article-title":"Cancer prevention from the perspective of global cancer burden patterns.","volume":"9","author":"Nagai","year":"2017","journal-title":"J Thorac Dis."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114599","article-title":"Cancer treatment-related cardiovascular disease: current status and future research priorities.","volume":"190","author":"Nonaka","year":"2021","journal-title":"Biochem Pharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ijcard.2021.02.025","article-title":"Cardiovascular disease-specific mortality in 270,618 patients with non-small cell lung cancer.","volume":"330","author":"Sun","year":"2021","journal-title":"Int J Cardiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1200\/JCO.2016.70.0229","article-title":"Cardiac toxicity after radiotherapy for stage III non-small-cell lung cancer: pooled analysis of dose-escalation trials delivering 70 to 90 Gy.","volume":"35","author":"Wang","year":"2017","journal-title":"J Clin Oncol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1200\/JCO.2016.71.6142","article-title":"Cardiac events after radiation therapy: combined analysis of prospective multicenter trials for locally advanced non-small-cell lung cancer.","volume":"35","author":"Dess","year":"2017","journal-title":"J Clin Oncol."},{"key":"B14","first-page":"2918","article-title":"Cardiovascular disease and its relationship with chronic kidney disease.","volume":"18","author":"Liu","year":"2014","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1177\/2048004016687211","article-title":"Primary prevention of cardiovascular disease: a review of contemporary guidance and literature.","volume":"6","author":"Stewart","year":"2017","journal-title":"JRSM Cardiovasc Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/IPRP.S133088","article-title":"Cardiovascular disease as a leading cause of death: how are pharmacists getting involved?","volume":"8","author":"Mc Namara","year":"2019","journal-title":"Integr Pharm Res Pract."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1001\/jamapsychiatry.2015.1737","article-title":"Premature mortality among adults with schizophrenia in the United States.","volume":"72","author":"Olfson","year":"2015","journal-title":"JAMA Psychiatry."},{"key":"B18","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1093\/annonc\/mdw604","article-title":"Causes of death among cancer patients.","volume":"28","author":"Zaorsky","year":"2017","journal-title":"Ann Oncol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.1016\/j.jacc.2019.03.500","article-title":"Cardiac radiation dose, cardiac disease, and mortality in patients with lung cancer.","volume":"73","author":"Atkins","year":"2019","journal-title":"J Am Coll Cardiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1001\/jamainternmed.2015.1180","article-title":"Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk.","volume":"175","author":"van Nimwegen","year":"2015","journal-title":"JAMA Intern Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1200\/JCO.2015.63.4444","article-title":"Radiation dose-response relationship for risk of coronary heart disease in survivors of Hodgkin lymphoma.","volume":"34","author":"van Nimwegen","year":"2016","journal-title":"J Clin Oncol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.lungcan.2019.08.025","article-title":"Increased risk of coronary heart disease and stroke in lung cancer survivors: a Korean nationwide study of 20,458 patients.","volume":"136","author":"Yoon","year":"2019","journal-title":"Lung Cancer."},{"key":"B23","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.ijrobp.2009.09.064","article-title":"Radiation-related heart disease: current knowledge and future prospects.","volume":"76","author":"Darby","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"B24","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jtho.2020.11.002","article-title":"Cardiac toxicity of thoracic radiotherapy: existing evidence and future directions.","volume":"16","author":"Banfill","year":"2021","journal-title":"J Thorac Oncol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1038\/s41416-021-01549-w","article-title":"Cardiovascular mortality among cancer survivors who developed breast cancer as a second primary malignancy.","volume":"125","author":"Wang","year":"2021","journal-title":"Br J Cancer."},{"key":"B26","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.annonc.2019.10.023","article-title":"Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations.","volume":"31","author":"Curigliano","year":"2020","journal-title":"Ann Oncol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e1166","DOI":"10.1259\/bjr\/25026140","article-title":"Radiation-induced cancer: a modern view.","volume":"85","author":"Shah","year":"2012","journal-title":"Br J Radiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3857\/roj.2017.00108","article-title":"Multidisciplinary team approach for the management of patients with locally advanced non-small cell lung cancer: searching the evidence to guide the decision.","volume":"35","author":"Oh","year":"2017","journal-title":"Radiat Oncol J."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005051","article-title":"Radiation-induced heart disease in lung cancer radiotherapy: a dosimetric update.","volume":"95","author":"Ming","year":"2016","journal-title":"Medicine (Baltimore)."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.023802","article-title":"Association between radiotherapy and death from cardiovascular disease among patients with cancer: a large population-based cohort study.","volume":"11","author":"Liu","year":"2022","journal-title":"J Am Heart Assoc."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2019.111161","article-title":"Changes of the coronary arteries and cardiac microvasculature with aging: implications for translational research and clinical practice.","volume":"184","author":"Piccirillo","year":"2019","journal-title":"Mech Ageing Dev."},{"key":"B32","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1146\/annurev-pathmechdis-012419-032544","article-title":"Cardiovascular disease, aging, and clonal hematopoiesis.","volume":"15","author":"Evans","year":"2020","journal-title":"Annu Rev Pathol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"s41","DOI":"10.7861\/clinmedicine.18-2-s41","article-title":"Recent advances in the management of lung cancer.","volume":"18","author":"Jones","year":"2018","journal-title":"Clin Med (Lond)."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.610638","article-title":"Comparison of lobectomy and sublobar resection for stage IA elderly NSCLC patients (>\/=70 Years): a population-based propensity score matching\u2019s study.","volume":"11","author":"Zhang","year":"2021","journal-title":"Front Oncol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lungcan.2020.05.004","article-title":"Cardiovascular mortality and morbidity following radical radiotherapy for lung cancer: is cardiovascular death under-reported?","volume":"146","author":"Sun","year":"2020","journal-title":"Lung Cancer."},{"key":"B36","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/s0167-8140(02)00009-9","article-title":"Rotterdam oncological thoracic study G Has 3-D conformal radiotherapy (3D CRT) improved the local tumour control for stage I non-small cell lung cancer?","volume":"63","author":"Lagerwaard","year":"2002","journal-title":"Radiother Oncol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/s1388-9842(00)00067-2","article-title":"Cardiovascular disease and outcome of acute stroke: influence of pre-existing cardiac failure.","volume":"2","author":"Sharma","year":"2000","journal-title":"Eur J Heart Fail."},{"key":"B38","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1007\/s00264-021-05227-7","article-title":"Risk of post-operative cardiovascular event in elderly patients with pre-existing cardiovascular disease who are undergoing hip fracture surgery.","volume":"45","author":"Luo","year":"2021","journal-title":"Int Orthop."},{"key":"B39","doi-asserted-by":"publisher","first-page":"6525","DOI":"10.2147\/CMAR.S174801","article-title":"Radiotherapy improves the survival of patients with extensive-disease small-cell lung cancer: a propensity score matched analysis of surveillance, epidemiology, and end results database.","volume":"10","author":"Zhang","year":"2018","journal-title":"Cancer Manag Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"10767","DOI":"10.2147\/CMAR.S221225","article-title":"Thoracic radiotherapy benefits elderly extensive-stage small cell lung cancer patients with distant metastasis.","volume":"11","author":"Qi","year":"2019","journal-title":"Cancer Manag Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s43018-021-00181-0","article-title":"Emerging strategies for treating metastasis.","volume":"2","author":"Esposito","year":"2021","journal-title":"Nat Cancer."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial.","volume":"393","author":"Palma","year":"2019","journal-title":"Lancet."},{"key":"B43","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","article-title":"Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial.","volume":"22","author":"Bahadoer","year":"2021","journal-title":"Lancet Oncol."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.34458","article-title":"Optimizing chemotherapy choice in the treatment of advanced pancreatic cancer-it is complicated.","volume":"4","author":"Tran","year":"2021","journal-title":"JAMA Netw Open."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1200\/JCO.20.03570","article-title":"Therapy for stage IV non-small-cell lung cancer with driver alterations: ASCO and OH (CCO) joint guideline update.","volume":"39","author":"Hanna","year":"2021","journal-title":"J Clin Oncol."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2019.08.107","article-title":"Radiation and cardiovascular disease.","volume":"7","author":"Palaskas","year":"2019","journal-title":"Ann Transl Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1016\/j.jtho.2020.06.014","article-title":"Incidence and onset of severe cardiac events after radiotherapy for esophageal cancer.","volume":"15","author":"Wang","year":"2020","journal-title":"J Thorac Oncol."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.1068957\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T05:33:36Z","timestamp":1673501616000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.1068957\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,12]]},"references-count":47,"alternative-id":["10.3389\/fcvm.2022.1068957"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.1068957","relation":{},"ISSN":["2297-055X"],"issn-type":[{"type":"electronic","value":"2297-055X"}],"subject":[],"published":{"date-parts":[[2023,1,12]]},"article-number":"1068957"}}